Biotica

📍 Cambridge, United Kingdom🗓 Founded 1996👥 18 employees💰 Last funded 2004
Biotechnology Research🌐 biotica.com
Website LinkedIn
Biotica discovers and develops novel polyketide therapeutics to create new medicines for serious diseases. Biotica’s R&D pipeline is focused on optimised polyketide therapeutics for high-value indications. Biotica's compounds, generated using the proprietary novoPT™ technology, have unique chemistry and differentiated properties. Polyketides are the basis of more than 40 successful therapeutics in a wide range of diseases. They make excellent leads for drug discovery, with naturally high affinity to biologically relevant targets, including protein-protein interactions and other traditionally difficult targets. Biotica has formed successful partnerships with leading pharmaceutical companies, most recently Wyeth and GSK, based on its high-value projects. Projects are selected on three key criteria: market potential, clinical validation of the target and Biotica exclusivity.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
1996
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Biotica?
Biotica has 2 investors on record on gritt.io and 2 late-stage investors.
When did Biotica last raise funding?
The most recent investment in Biotica recorded on gritt.io was in 2004.
When was Biotica founded?
Biotica was founded in 1996.
What industry is Biotica in?
Biotica operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biotica based?
Biotica is headquartered in Cambridge, United Kingdom.